Deng S, Ding L, Qian Y, Huang X
J Asthma Allergy. 2025; 18:307-330.
PMID: 40046173
PMC: 11881607.
DOI: 10.2147/JAA.S490039.
Ibrahim S, Khan M, Khurram I, Rehman R, Rauf A, Ahmad Z
Food Sci Nutr. 2025; 13(2):e70011.
PMID: 39898116
PMC: 11786021.
DOI: 10.1002/fsn3.70011.
Ou L, Setegne M, Elliot J, Shen F, Dassama L
Chem Rev. 2025; 125(4):2120-2183.
PMID: 39818743
PMC: 11870016.
DOI: 10.1021/acs.chemrev.4c00595.
An Y, Guo C, Wang X, Liu J, Li Z, Ding J
J Cell Mol Med. 2025; 29(1):e70320.
PMID: 39804798
PMC: 11728483.
DOI: 10.1111/jcmm.70320.
Chen P, Hu J, Liu Y, Cao B, Song X
Proc Natl Acad Sci U S A. 2025; 122(1):e2414016122.
PMID: 39793039
PMC: 11725920.
DOI: 10.1073/pnas.2414016122.
The Role and Mechanism of TRIM Proteins in Gastric Cancer.
Wu W, Yang J, Yu T, Zou Z, Huang X
Cells. 2025; 13(24.
PMID: 39768197
PMC: 11674240.
DOI: 10.3390/cells13242107.
Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation.
Sirera J, Sarlak S, Teisseire M, Carminati A, Nicolini V, Savy C
J Exp Clin Cancer Res. 2024; 43(1):335.
PMID: 39736693
PMC: 11686864.
DOI: 10.1186/s13046-024-03241-2.
Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.
Sabeh P, Dumas S, Maios C, Daghar H, Korzeniowski M, Rousseau J
Am J Hum Genet. 2024; 112(1):75-86.
PMID: 39721588
PMC: 11739880.
DOI: 10.1016/j.ajhg.2024.11.009.
hair growth-promoting effects of araliadiol via the p38/PPAR-γ signaling pathway in human hair follicle stem cells and dermal papilla cells.
Park S, Park H, Seo D, Yoo D, Bae S
Front Pharmacol. 2024; 15:1482898.
PMID: 39691387
PMC: 11649413.
DOI: 10.3389/fphar.2024.1482898.
Different Proteins as Biomarkers for Sac Shrinkage After Endovascular Aortic Repair of Abdominal Aortic Aneurysms.
Zimmermann A, Reitnauer D, Yundung Y, Menges A, Meuli L, Pelisek J
J Cardiovasc Dev Dis. 2024; 11(11).
PMID: 39590217
PMC: 11594911.
DOI: 10.3390/jcdd11110374.
TRIM46 accelerates H1N1 influenza virus-induced ferroptosis and inflammatory response by regulating SLC7A11 ubiquitination.
Zhou C, Bao G, Chen Y
J Bioenerg Biomembr. 2024; 56(6):631-643.
PMID: 39531094
DOI: 10.1007/s10863-024-10043-w.
Acanthamoeba polyphaga de novo transcriptome and its dynamics during Mimivirus infection.
Bickels Nuri R, Feldmesser E, Fridmann-Sirkis Y, Keren-Shaul H, Nevo R, Minsky A
Sci Rep. 2024; 14(1):25894.
PMID: 39472705
PMC: 11522460.
DOI: 10.1038/s41598-024-76078-6.
Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis.
Zhang W, Zhang K
Cancer Inform. 2024; 23():11769351241276319.
PMID: 39444678
PMC: 11497523.
DOI: 10.1177/11769351241276319.
MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1.
Shen S, Liu R, Huang J, Sun Y, Tan Q, Luo Q
Cell Death Dis. 2024; 15(10):768.
PMID: 39438468
PMC: 11496809.
DOI: 10.1038/s41419-024-07113-7.
Proteomic Characterization of Ubiquitin Carboxyl-Terminal Hydrolase 19 Deficient Cells Reveals a Role for USP19 in the Secretion of Lysosomal Proteins.
Bonelli S, Lo Pinto M, Ye Y, Muller S, Lichtenthaler S, Scilabra S
Mol Cell Proteomics. 2024; 23(11):100854.
PMID: 39389361
PMC: 11617723.
DOI: 10.1016/j.mcpro.2024.100854.
Enhanced feature matching in single-cell proteomics characterizes IFN-γ response and co-existence of cell states.
Krull K, Ali S, Krijgsveld J
Nat Commun. 2024; 15(1):8262.
PMID: 39327420
PMC: 11427561.
DOI: 10.1038/s41467-024-52605-x.
ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.
Hernandez-Carralero E, Quinet G, Freire R
Expert Rev Mol Med. 2024; 26:e19.
PMID: 39320846
PMC: 11440613.
DOI: 10.1017/erm.2024.10.
VMA21: unveiling a novel oncogene that facilitates immune evasion in triple-negative breast cancer through TCIRG1 protein stability regulation.
Guo X, Chen Z, Miao Y, Zhang G, Miao L
Am J Cancer Res. 2024; 14(8):4096-4111.
PMID: 39267677
PMC: 11387875.
DOI: 10.62347/NGSD3193.
Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors.
Wang Q, Zhu Y, Pei J
Future Med Chem. 2024; 16(18):1923-1944.
PMID: 39206853
PMC: 11485768.
DOI: 10.1080/17568919.2024.2389764.
Different Strategies to Overcome Resistance to Proteasome Inhibitors-A Summary 20 Years after Their Introduction.
Tyrna P, Procyk G, Szeleszczuk L, Mlynarczuk-Bialy I
Int J Mol Sci. 2024; 25(16).
PMID: 39201634
PMC: 11354503.
DOI: 10.3390/ijms25168949.